JP2021516049A5 - - Google Patents
Info
- Publication number
- JP2021516049A5 JP2021516049A5 JP2020545519A JP2020545519A JP2021516049A5 JP 2021516049 A5 JP2021516049 A5 JP 2021516049A5 JP 2020545519 A JP2020545519 A JP 2020545519A JP 2020545519 A JP2020545519 A JP 2020545519A JP 2021516049 A5 JP2021516049 A5 JP 2021516049A5
- Authority
- JP
- Japan
- Prior art keywords
- virus
- cancer
- cells
- tcr
- tumor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023212042A JP2024037917A (ja) | 2018-03-01 | 2023-12-15 | 組換えｔ細胞受容体遺伝子を用いて細胞ベースの治療薬を製造するための技法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862637240P | 2018-03-01 | 2018-03-01 | |
| US62/637,240 | 2018-03-01 | ||
| PCT/US2019/019754 WO2019168923A1 (en) | 2018-03-01 | 2019-02-27 | Techniques for generating cell-based therapeutics using recombinant t cell receptor genes |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023212042A Division JP2024037917A (ja) | 2018-03-01 | 2023-12-15 | 組換えｔ細胞受容体遺伝子を用いて細胞ベースの治療薬を製造するための技法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021516049A JP2021516049A (ja) | 2021-07-01 |
| JP2021516049A5 true JP2021516049A5 (https=) | 2022-02-28 |
Family
ID=67806393
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020545519A Pending JP2021516049A (ja) | 2018-03-01 | 2019-02-27 | 組換えｔ細胞受容体遺伝子を用いて細胞ベースの治療薬を製造するための技法 |
| JP2023212042A Pending JP2024037917A (ja) | 2018-03-01 | 2023-12-15 | 組換えｔ細胞受容体遺伝子を用いて細胞ベースの治療薬を製造するための技法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023212042A Pending JP2024037917A (ja) | 2018-03-01 | 2023-12-15 | 組換えｔ細胞受容体遺伝子を用いて細胞ベースの治療薬を製造するための技法 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US12178831B2 (https=) |
| EP (2) | EP3759133A4 (https=) |
| JP (2) | JP2021516049A (https=) |
| KR (1) | KR20210006330A (https=) |
| CN (1) | CN112119086A (https=) |
| AU (1) | AU2019227700B2 (https=) |
| CA (1) | CA3092794A1 (https=) |
| WO (1) | WO2019168923A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017192536A1 (en) * | 2016-05-02 | 2017-11-09 | University Of Kansas | Eliminating mhc restriction from the t cell receptor as a strategy for immunotherapy |
| WO2021150903A1 (en) * | 2020-01-22 | 2021-07-29 | Atreca, Inc. | High throughput linking of multiple transcripts |
| WO2022242359A1 (zh) * | 2021-05-20 | 2022-11-24 | 中国科学院广州生物医药与健康研究院 | 一种体液免疫系统再生的方法及其应用 |
| CN119677842A (zh) * | 2022-03-17 | 2025-03-21 | 科士华(南京)生物技术有限公司 | 人工合成肿瘤浸润淋巴细胞 |
| US20250216381A1 (en) * | 2022-03-21 | 2025-07-03 | Alaunos Therapeutics, Inc. | Methods for Identifying Neoantigen-Reactive T Cell Receptors |
| WO2023237541A1 (en) * | 2022-06-07 | 2023-12-14 | Gadeta B.V. | Delta t-cell or gamma t-cell receptor chains or parts thereof that mediate an anti-tumour or anti-infective response |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| US6924123B2 (en) | 1996-10-29 | 2005-08-02 | Oxford Biomedica (Uk) Limited | Lentiviral LTR-deleted vector |
| US7419829B2 (en) | 2000-10-06 | 2008-09-02 | Oxford Biomedica (Uk) Limited | Vector system |
| IL157335A0 (en) | 2001-03-13 | 2004-02-19 | Novartis Ag | Lentiviral packaging constructs |
| DE10132440A1 (de) | 2001-07-04 | 2003-01-23 | Bosch Gmbh Robert | System und Verfahren zum Überwachen des Fahrverhaltens eines Fahrzeugs |
| US8709762B2 (en) * | 2010-03-02 | 2014-04-29 | Bio-Rad Laboratories, Inc. | System for hot-start amplification via a multiple emulsion |
| US9233125B2 (en) | 2010-12-14 | 2016-01-12 | University Of Maryland, Baltimore | Universal anti-tag chimeric antigen receptor-expressing T cells and methods of treating cancer |
| WO2013044225A1 (en) | 2011-09-22 | 2013-03-28 | The Trustees Of The University Of Pennsylvania | A universal immune receptor expressed by t cells for the targeting of diverse and multiple antigens |
| EP2861760B1 (en) | 2012-06-15 | 2020-01-01 | The Board of Regents of The University of Texas System | High throughput sequencing of multiple transcripts of a single cell |
| WO2013192570A1 (en) * | 2012-06-21 | 2013-12-27 | Gigagen, Inc. | System and methods for genetic analysis of mixed cell populations |
| CN113005091A (zh) | 2013-02-06 | 2021-06-22 | 细胞基因公司 | 具有改进特异性的修饰的t淋巴细胞 |
| DK2956175T3 (da) | 2013-02-15 | 2017-11-27 | Univ California | Kimærisk antigenreceptor og fremgangsmåder til anvendelse deraf |
| RU2578009C2 (ru) * | 2013-05-08 | 2016-03-20 | Закрытое акционерное общество "ЕВРОГЕН" | Способ идентификации нативных пар фрагментов днк или рнк, присутствующих в одних и тех же живых клетках |
| CN105814083A (zh) | 2013-10-15 | 2016-07-27 | 加州生物医学研究所 | 嵌合抗原受体t细胞开关和其用途 |
| CN105829349B (zh) | 2013-10-15 | 2023-02-03 | 斯克利普斯研究所 | 肽嵌合抗原受体t细胞开关和其用途 |
| US10934346B2 (en) * | 2014-02-14 | 2021-03-02 | Bellicum Pharmaceuticals, Inc. | Modified T cell comprising a polynucleotide encoding an inducible stimulating molecule comprising MyD88, CD40 and FKBP12 |
| NZ724320A (en) | 2014-03-14 | 2022-05-27 | Adaptimmune Ltd | Tcr libraries |
| CN104091269A (zh) | 2014-06-30 | 2014-10-08 | 京东方科技集团股份有限公司 | 一种虚拟试衣方法及虚拟试衣系统 |
| KR20170032406A (ko) | 2014-07-15 | 2017-03-22 | 주노 쎄러퓨티크스 인코퍼레이티드 | 입양 세포 치료를 위한 조작된 세포 |
| CA2964958A1 (en) | 2014-10-31 | 2016-05-06 | The Trustees Of The University Of Pennsylvania | Methods and compositions for modified t cells |
| HK1245827B (en) | 2014-12-15 | 2020-06-19 | Board Of Regents Of The University Of Texas System | Methods for controlled activation or elimination of therapeutic cells |
| EP3234144B1 (en) | 2014-12-15 | 2020-08-26 | Bellicum Pharmaceuticals, Inc. | Methods for controlled elimination of therapeutic cells |
| EP4286511A3 (en) | 2015-06-12 | 2024-03-06 | Lentigen Technology, Inc. | Method to treat cancer with engineered t-cells |
| GB2592821B (en) * | 2015-07-31 | 2022-01-12 | Univ Minnesota | Modified cells and methods of therapy |
| MX2018003532A (es) * | 2015-09-24 | 2019-04-25 | Abvitro Llc | Conjugados de afinidad-oligonucleotido y usos de los mismos. |
| MX2018003534A (es) * | 2015-09-25 | 2019-04-25 | Abvitro Llc | Proceso de alto rendimiento para identificacion de blanco de receptor de celula t de secuencias de receptor de celula t apareadas de manera natural. |
| US12297427B2 (en) * | 2015-12-04 | 2025-05-13 | St. Jude Children's Research Hospital, Inc. | Cloning and expression system for T-cell receptors |
| DK3399985T3 (da) * | 2016-01-06 | 2022-03-21 | Health Research Inc | Sammensætninger og biblioteker, der omfatter rekombinante T-cellereceptorer, og fremgangsmåder til anvendelse af rekombinante T-cellereceptorer |
| EP3443087B1 (en) * | 2016-04-12 | 2024-09-18 | Medimmune, LLC | Immune repertoire mining |
-
2019
- 2019-02-27 WO PCT/US2019/019754 patent/WO2019168923A1/en not_active Ceased
- 2019-02-27 EP EP19761362.3A patent/EP3759133A4/en not_active Withdrawn
- 2019-02-27 KR KR1020207027921A patent/KR20210006330A/ko active Pending
- 2019-02-27 CN CN201980029596.9A patent/CN112119086A/zh active Pending
- 2019-02-27 EP EP24214219.8A patent/EP4495246A3/en active Pending
- 2019-02-27 JP JP2020545519A patent/JP2021516049A/ja active Pending
- 2019-02-27 US US16/976,983 patent/US12178831B2/en active Active
- 2019-02-27 AU AU2019227700A patent/AU2019227700B2/en active Active
- 2019-02-27 CA CA3092794A patent/CA3092794A1/en active Pending
-
2023
- 2023-12-15 JP JP2023212042A patent/JP2024037917A/ja active Pending
-
2024
- 2024-11-21 US US18/955,752 patent/US20250154222A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021516049A5 (https=) | ||
| US11123369B2 (en) | Bispecific CAR T-cells for solid tumor targeting | |
| JP7755890B2 (ja) | Ｃａｒ発現ベクター及びｃａｒ発現ｔ細胞 | |
| CN110072885B (zh) | TGFβ信号转换器 | |
| JP6686008B2 (ja) | がん特異的突然変異に対し抗原特異性を有するｔ細胞受容体を単離する方法 | |
| JP7696658B2 (ja) | ヒトメソセリンを特異的に認識する細胞表面分子、ｉｌ－７、及びｃｃｌ１９を発現する免疫担当細胞 | |
| US10759868B2 (en) | Trophoblast glycoprotein (5T4, TPBG) specific chimeric antigen receptors for cancer immunotherapy | |
| JP2022513652A5 (https=) | ||
| IL269538B2 (en) | Universal anti–cd22 chimeric antigen receptor transgenic immune cells | |
| JP7636650B2 (ja) | 二量体形成剤調節性免疫受容体複合体 | |
| TW201734205A (zh) | 表現免疫機能控制因子之免疫活性細胞及表現載體 | |
| JP2021518160A5 (https=) | ||
| JP2017512054A (ja) | 三官能性ｔ細胞−抗原カプラ及び方法並びにこれらの使用 | |
| JP7431735B2 (ja) | Ｄａｒｉｃインターロイキン受容体 | |
| KR20160030480A (ko) | Ｃｄ19 특이적 키메라 항원 수용체 및 이의 용도 | |
| WO2019090355A1 (en) | Cells expressing antibodies and methods of treatment using the same | |
| JP2024525727A (ja) | 抗体由来の結合ドメインに融合した操作されたｔ細胞受容体 | |
| JP7747724B2 (ja) | マウス定常領域を伴うｔｃｒを発現する細胞を選択的に増幅するための方法 | |
| JP2024540099A (ja) | Ｒｏｒ１結合タンパク質を発現する細胞を培養する方法 | |
| JP2024540103A (ja) | ｃ－Ｊｕｎを発現する細胞を培養するための方法 | |
| CN118451098A (zh) | 培养表达c-jun的细胞的方法 | |
| JP7437444B2 (ja) | がん特異的突然変異に対し抗原特異性を有するｔ細胞受容体を単離する方法 | |
| Famili et al. | and Frank JT Staal |